AlphaStocks
4.2
Weak

ABBOTT LABORATORIES (ABT)

Health Care / Health Care Equipment

S&P 500

$88.43

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

#787out of 1124 in Health Care

Is ABBOTT LABORATORIES a Good Investment in 2026?

ABBOTT LABORATORIES (ABT) scores 4.2 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Buffett model rates ABBOTT LABORATORIES as Strong. The Lynch model is the least favorable, rating it Neutral. ABBOTT LABORATORIES currently trades below its estimated fair value of $107, suggesting potential upside. ABBOTT LABORATORIES ranks #787 out of 1124 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E23.7ROE12.7Market Cap154BDiv Yield2.6

Estimated Fair Value

$107.1017% below

Fair value above market price. P/E of 24x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Strong

Business quality & competitive moat

Graham

Neutral

83% above fair value

Lynch

Neutral

PEG 3.4 · Stalwart

Greenblatt

Attractive

Top 25% (rank 19%)

Frequently Asked Questions

Is ABBOTT LABORATORIES (ABT) a good investment?
Based on AlphaStocks' composite analysis, ABBOTT LABORATORIES (ABT) scores 4.2 out of 10, earning a Weak rating. This score is below average, suggesting caution. Fair value above market price. P/E of 24x is moderate for this quality level.
What is ABBOTT LABORATORIES's Piotroski F-Score?
ABBOTT LABORATORIES's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ABT overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $107, ABT appears undervalued. The stock currently trades 17% below its estimated fair value. Fair value above market price. P/E of 24x is moderate for this quality level.
How does ABT compare to other Health Care stocks?
ABBOTT LABORATORIES ranks #787 out of 1124 stocks in the Health Care sector, placing it in the top 70% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about ABT?
AlphaStocks evaluates ABT using five proven investment models. Piotroski: Attractive; Buffett: Strong; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 4.2/10.

Similar Stocks

BFAMPARRAZN

Compare ABT with

ABT vs BFAMABT vs PARRABT vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer